← Back to Search

Clinical Decision Support Tool

Electronic Medical Record Support for Diabetes Management

N/A
Recruiting
Led By Ariana Pichardo-Lowden, MD
Research Sponsored by Milton S. Hershey Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Hospitalized adult (>18 years) patients at Penn State Health, Hershey Medical Center, St. Joseph's Hospital, Hampden Medical Center, and Holy Spirit Medical Center
Ambulatory adult (>18 years) patients at Penn State Health, Hershey Medical Center
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 months
Awards & highlights

Study Summary

This trial looks at whether using an electronic medical record clinical decision support tool can help manage dysglycemia in the hospital and improve outcomes.

Who is the study for?
This trial is for adults over 18 years old with conditions like prediabetes, diabetes, and varying blood sugar levels who are hospitalized or visiting outpatient clinics at specific Penn State Health centers. Children under 18 cannot participate.Check my eligibility
What is being tested?
The study is testing an electronic tool that helps doctors make decisions about diabetes care in hospitals. It looks at how the tool affects blood sugar control and its impact on clinical outcomes and costs.See study design
What are the potential side effects?
Since this trial involves a decision support tool rather than medication, traditional side effects are not applicable. However, there may be indirect effects on patient care based on the tool's recommendations.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am an adult patient hospitalized at a specified Penn State Health center.
Select...
I am over 18 and can walk on my own. I am a patient at Penn State Health, Hershey Medical Center.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Average hospital length of stay (LOS)
Secondary outcome measures
Average reduction of glycohemoglobin level within 12 months of discharge
Cost of hospitalization
Frequency of Intensive Care unit (ICU) transfers
+17 more
Other outcome measures
Provider's decision making
Provider's knowledge
Provider's perspective
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Active Inpatient Diabetes Clinical Decision SupportExperimental Treatment1 Intervention
The Active arm consists of participants treated during the "ON" phase of the GlucAlert-CDS tool. The tool operates through an automated process of rules embedded in the EMR recognizing hypoglycemia (established or impending); recurrent hyperglycemia (in type 1 and 2 DM, or stress hyperglycemia-SH); and inappropriate insulin use (sliding scales monotherapy if recurrent hyperglycemia in type 2 DM or SH, or any time in type 1 DM). If the tool's criteria are met, an alert in the EMR will notify the provider with the clinically recommended treatment.
Group II: Inactive Inpatient Diabetes Clinical Decision SupportActive Control1 Intervention
The Inactive arm consists of participants treated during the "OFF" phase of the GlucAlert-CDS Tool. Alerts will not be sent to provider's

Find a Location

Who is running the clinical trial?

Milton S. Hershey Medical CenterLead Sponsor
491 Previous Clinical Trials
2,783,073 Total Patients Enrolled
2 Trials studying Diabetes
2,622,165 Patients Enrolled for Diabetes
National Institutes of Health (NIH)NIH
2,685 Previous Clinical Trials
6,915,064 Total Patients Enrolled
24 Trials studying Diabetes
48,445 Patients Enrolled for Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,348 Previous Clinical Trials
4,299,000 Total Patients Enrolled
106 Trials studying Diabetes
122,931 Patients Enrolled for Diabetes

Media Library

Active Electronic Medical Record Inpatient Diabetes Clinical Decision Support (Clinical Decision Support Tool) Clinical Trial Eligibility Overview. Trial Name: NCT05447806 — N/A
Diabetes Research Study Groups: Active Inpatient Diabetes Clinical Decision Support, Inactive Inpatient Diabetes Clinical Decision Support
Diabetes Clinical Trial 2023: Active Electronic Medical Record Inpatient Diabetes Clinical Decision Support Highlights & Side Effects. Trial Name: NCT05447806 — N/A
Active Electronic Medical Record Inpatient Diabetes Clinical Decision Support (Clinical Decision Support Tool) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05447806 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor presently seeking participants?

"As per the clinicaltrials.gov data, recruitment for this medical trial is ongoing; it was initially published on July 15th 2022 and edited most recently in August 31st of that same year."

Answered by AI

What is the capacity of this clinical trial in terms of participants?

"Affirmative. The info available on clinicaltrials.gov states that this research is in need of participants, with the trial having been initially posted on July 15th 2022 and last updated on August 31st 2022. To successfully carry out the study, 15732 people must register at two separate sites."

Answered by AI
~6742 spots leftby Jul 2025